CIK 0001755237
- Non-accelerated filer
- Smaller reporting company
Korsana Biosciences, Inc.
Sign in to watch- Ticker
- KRSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 831895370
- Phone
- +1 781-516-2325
- Business address
- 203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
- Former names
- Cyclerion Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 626,117 shares at $16.00 ($10,017,872)
- 4 Open-market buy Director bought 626,117 shares at $16.00 ($10,017,872)
- 4/A Grant or award Director acquired 2,421 shares (grant or award)
- 4 Grant or award Director acquired 18,120 shares (grant or award)
- 4/A Grant or award Director acquired 16,950 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 224,647 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President bought 270,107 shares at $14.81 ($4,000,285)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 77,506 shares (grant or award)
- 4 Grant or award Director acquired 7,508 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 16,950 shares (grant or award)
- 4 Grant or award Director acquired 2,421 shares (grant or award)
Page 6 of 7 · 134 filings